KK-LC-1 targeted T cell receptor gene therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for KK-LC-1 targeted T cell receptor gene therapy, covering 2025-12-02 to 2025-12-02. Get the full timeline:
Most recent: Clinical Trial Update: T Cell Receptor Gene Therapy Targeting KK-LC-1 for Gastric, Breast, Cervical, Lung and Other KK-LC-1 Positive Epithelial Cancers [Phase 1]